BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27310819)

  • 1. Identification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot study.
    van Erp SJ; Leicher LW; Hennink SD; Ghorbanoghli Z; Breg SA; Morreau H; Nielsen M; Hardwick JC; Roukema JA; Langers AM; de Vos Tot Nederveen Cappel WH; Vasen HF
    Scand J Gastroenterol; 2016 Oct; 51(10):1227-32. PubMed ID: 27310819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
    Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
    Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
    Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High detection rate of adenomas in familial colorectal cancer.
    van der Meulen-de Jong AE; Morreau H; Becx MC; Crobach LF; van Haastert M; ten Hove WR; Kleibeuker JH; Meijssen MA; Nagengast FM; Rijk MC; Salemans JM; Stronkhorst A; Tuynman HA; Vecht J; Verhulst ML; de Vos tot Nederveen Cappel WH; Walinga H; Weinhardt OK; Westerveld BD; Witte AM; Wolters HJ; Vasen HF
    Gut; 2011 Jan; 60(1):73-6. PubMed ID: 20833659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
    Bjerrum A; Andersen O; Fischer A; Lindebjerg J; Lynge E
    Int J Cancer; 2017 Aug; 141(3):503-511. PubMed ID: 28463410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Colonoscopic screening in first-degree relatives of patients with sporadic colorectal cancer].
    Scintu F; Canalis C; Capra F; D'Alia G; Giordano M; Mocci P; Pisano M; Casula G
    Ann Ital Chir; 2000; 71(6):693-9. PubMed ID: 11347322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.
    Bjerrum A; Milter MC; Andersen O; Fischer A; Lynge E
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1433-7. PubMed ID: 26352132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dedicated high-quality service for the management of patients with an inherited risk of colorectal cancer.
    Adams LK; Qiu S; Hunt AK; Monahan KJ
    Colorectal Dis; 2019 Aug; 21(8):879-885. PubMed ID: 30903731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer.
    Sjöström O; Lindholm L; Tavelin B; Melin B
    Fam Cancer; 2016 Oct; 15(4):543-51. PubMed ID: 26935832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonoscopy requirements of population screening for colorectal cancer in New Zealand.
    Green T; Richardson A; Parry S
    N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study.
    Dove-Edwin I; Sasieni P; Adams J; Thomas HJ
    BMJ; 2005 Nov; 331(7524):1047. PubMed ID: 16243849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer.
    Gaglia P; Atkin WS; Whitelaw S; Talbot IC; Williams CB; Northover JM; Hodgson SV
    Gut; 1995 Mar; 36(3):385-90. PubMed ID: 7698698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer.
    Mesher D; Dove-Edwin I; Sasieni P; Vasen H; Bernstein I; Royer-Pokora B; Holinski-Feder E; Lalloo F; Evans DG; Forsberg A; Lindblom A; Thomas H
    Int J Cancer; 2014 Feb; 134(4):939-47. PubMed ID: 23901040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
    Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
    Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Can an online risk assessment tool for identification of hereditary colorectal cancer reach the at-risk population and influence screening compliance?].
    Schürmanns K; Gelos M; Felder G; Schneider R; Möslein G
    Dtsch Med Wochenschr; 2014 May; 139(18):935-40. PubMed ID: 24760714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonoscopy: a review of its yield for cancers and adenomas by indication.
    Rex DK
    Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical identification and long-term surveillance of 22 hereditary non-polyposis colon cancer Italian families.
    Arrigoni A; Sprujevnik T; Alvisi V; Rossi A; Ricci G; Pennazio M; Spandre M; Cavallero M; Bertone A; Foco A; Rossini FP
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):213-9. PubMed ID: 15674100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.